{"title": "Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation - Full Text View - ClinicalTrials.gov", "author": null, "url": "https://clinicaltrials.gov/ct2/show/NCT04388358", "hostname": "clinicaltrials.gov", "description": "Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation - Full Text View.", "sitename": "ClinicalTrials.gov", "date": "2020-05-14", "cleaned_text": "Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation | The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our | |ClinicalTrials.gov Identifier: NCT04388358| | | Recruitment Status : Completed First Posted : May 14, 2020 Last Update Posted : February 9, 2021 - Study Details [Tabular View](/ct2/show/record/NCT04388358) [No the Effects of Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation in Humans| |Actual Study Date Primary Date :||October | formula | Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day | Drug: Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day | All patients were treated with mixed formula of Chinese medicine for one month - Serum IgE level assessments and MAST test [ Time Frame: On starting day (day 0) ]check serum total IgE and mite specific IgE - CD4+ Cell isolation and purification [ Time Frame: Assessment of CD4+ on Day 0 and 1 month after completing treatment ]check CD4 Cell by flowcytometry - Quantification of mRNA expression by means of RT-PCR and real-time PCR [ Time Frame: Assessment of mRNA on Day 0 and 1 month after completing treatment ] - Gut microbiota data analysis procedures [ Time Frame: Assessment of gut microbiota on Day 0 and 1 month after completing treatment ]use cecal stool DNA purification and quantification of PCR (qPCR). Using Taxonomic Units (OTUs) cluster; Taxonomic profiling Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, [Learn About Clinical Studies.](/ct2/about-studies/learn) |Ages Eligible for Study:||20 Years to Years Eligible for Study:||All| |Accepts Healthy Volunteers:||No| Inclusion Criteria: - Volunteer for study enrollment and sign inform consent - Mite allergy confirmed by MAST test - Over 20 years old - Will have their blood collected twice and stool samples - Allergic rhinitis patients in the acute phase will be treated with mixed formula of Chinese medicine for one months Exclusion Criteria: - Women who are pregnant or breast-feeding - Under treatment of western medicine including steroid, antihistamine, leukotriene inhibitor, immunosuppressant or stop above medication less than one month - Under acute inflammatory disease such as pneumonia, sinusitis, bronchitis and so on vasomotor type allergic rhinitis - History of allergy or adverse effect to Chinese herbs, poor compliance of herbal medicine severe organ function impairment, such as heart failure, liver failure, renal failure (eGFR <60 mL/min/1.73 m2) To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier SIEN-HUNG, Director of Department of Traditional Chinese Gung Memorial Hospital| |ClinicalTrials.gov Identifier:|| Product:||No| | Perennial allergic rhinitis; Gut microbiota; Mixe formula of Chinese medicine | | Rhinitis | Rhinitis, Allergic Rhinitis, Allergic, Perennial Respiratory Tract Infections Infections Nose Diseases | Respiratory Tract Diseases | Otorhinolaryngologic Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases "}